Chu, Quincy Siu-Chung

Chu, Quincy Siu-Chung


Quincy Siu-Chung Chu is a Fellow of the Royal College of Physicians of Canada specializing in medical oncology.

  • Named a Future Leader in Oncology for 2011-2013 by oncologyeducation.com.
  • Teaches as associate professor at the University of Alberta.
  • Serves as a member of the Medical Advisory Team for Lung Cancer Canada.
  • Participates as a member of the Canadian Mesothelioma Foundation.
  • Has served as the principal investigator and subinvestigator for numerous novel anti-cancer agents.
  • Has written a number of articles dealing with advanced malignant tumors, lung cancer and soft-tissue sarcomas, which have been published in peer-reviewed journals.
  • Highest accruing physician for the Clinical Trial Unit within the Cross Cancer Institute.
  • Research interests include treating thoracic malignancies and sarcomas; phase I/II clinical trials of innovative anti-cancer agents (lung cancer falls under I and II; mesothelioma falls under II); molecular determinants of response and toxicities of innovative anti-cancer agents; and adult soft-tissue sarcomas.


Education:

  • M.D. degree from University of Toronto in Ontario, Canada.